| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 1 | 乳酸菌和/或双歧杆菌的存活能力提高剂 | CN201180050220.X | 2011-08-18 | CN103189499A | 2013-07-03 | 越智大辅; 木村胜纪 |
| 本发明涉及以氨基酸为有效成分的乳酸菌和/或双歧杆菌的存活能力提高剂。根据本发明，可以提高作为益生菌的乳酸菌和双歧杆菌在酸性(pH值低)环境中的存活能力。 | ||||||
| 2 | 空化的发酵乳制品 | CN201480082867.4 | 2014-10-21 | CN106998718A | 2017-08-01 | A.米蒙尼; J.罗梅罗; P.德蒙特 |
| 公开了具有至少5重量%的蛋白含量的空化的发酵乳制品和通过使发酵的乳制品通过空化器形成这些空化的发酵乳制品的方法。优选的乳制品为酸奶或希腊酸奶。 | ||||||
| 3 | 乳酸菌和/或双歧杆菌的存活能力提高剂 | CN201180050220.X | 2011-08-18 | CN103189499B | 2016-08-10 | 越智大辅; 木村胜纪 |
| 本发明涉及以氨基酸为有效成分的乳酸菌和/或双歧杆菌的存活能力提高剂。根据本发明，可以提高作为益生菌的乳酸菌和双歧杆菌在酸性(pH值低)环境中的存活能力。 | ||||||
| 4 | 包含乳酸菌或其处理物的脂质代谢和/或糖代谢改善剂 | CN201280059978.4 | 2012-12-06 | CN104010648A | 2014-08-27 | 仲村太志; 芦田延久; 石田优; 藤原茂 |
| 本发明提供改善脂质代谢和糖代谢两者的微生物的用途，具体而言，涉及脂质代谢和/或糖代谢改善剂、以及包含该改善剂的饮食品和药物组合物，所述脂质代谢和/或糖代谢改善剂的特征在于，包含具有针对过氧化物酶体增殖物激活受体(PPAR)α和过氧化物酶体增殖物激活受体(PPAR)γ的双重激动活性的、选自乳杆菌属和双歧杆菌属中的菌体、其菌体处理物或它们的混合物作为有效成分。 | ||||||
| 5 | Use Of Lactic Acid Bacteria To Reduce Pathogens And As A Bio-Sanitizer | US14236542 | 2012-07-31 | US20140341872A1 | 2014-11-20 | Douglas R. Ware; Philip G. Crandall; Steven C. Ricke |
| Compositions and methods are disclosed for improving food safety. One or more lactic acid producing microorganisms are shown to inhibit pathogenic contaminations on food materials. The lactic acid producing microorganisms are capable of adhering to various surfaces and may serve as a bio-sanitizing agent (or bio-sanitizer). Lactic acid producing microorganisms or cell free extract of these microorganisms may be used in an effective and natural method to prevent L. monocytogenes infection in food products, as well as in food processing facilities and equipments. | ||||||
| 6 | T CELL APOPTOSIS INDUCER | US13167483 | 2011-06-23 | US20110250189A1 | 2011-10-13 | Shigeru Fujiwara; Hiroki Kanzato; Satoshi Hachimura |
| An inducer of T cell apoptosis and a health food for inducing T cell apoptosis comprising as an active ingredient of a lactic acid bacterium belonging to the genus Lactobacillus or the genus Bifidobacterium are disclosed. Particularly preferred lactic acid bacteria belonging to the genus Lactobacillus or the genus Bifidobacterium are Lactobacillus acidophilus L-92 (FERM BP-4981), Lactobacillus amylovorus CP1750 (FERM BP-10532), Bifidobacterium catenulatum CP2829 (FERM BP-10533) and Bifidobacterium longum CP760 (FERM BP-10531). The inducer of T cell apoptosis of the invention is useful in the prevention and cure of a disease such as an organ-specific autoimmune disease or type I allergy. | ||||||
| 7 | Mixture of lactic bacteria for the preparation of gluten free baked products | US14622587 | 2015-02-13 | US09560854B2 | 2017-02-07 | Giammaria Giuliani; Anna Benedusi; Raffaella Di Cagno; Maria De Angelis; Antonella Luisi; Marco Gobbetti |
| The present invention concerns a mixture of lactic bacteria for yeasting of gluten-free baked products. Particularly, the invention concerns the use of “natural yeast” based on selected lactic bacteria as yeasting agent for the production of gluten-free bread, with improved sensory and nutritional property, designed for celiac patients feeding. | ||||||
| 8 | T cell apoptosis inducer and method therefore | US13167483 | 2011-06-23 | US09339055B2 | 2016-05-17 | Shigeru Fujiwara; Hiroki Kanzato; Satoshi Hachimura |
| An inducer of T cell apoptosis and a health food for inducing T cell apoptosis comprising as an active ingredient of a lactic acid bacterium belonging to the genus Lactobacillus or the genus Bifidobacterium are disclosed. Particularly preferred lactic acid bacteria belonging to the genus Lactobacillus or the genus Bifidobacterium are Lactobacillus acidophilus L-92 (FERM BP-4981), Lactobacillus amylovorus CP1750 (FERM BP-10532), Bifidobacterium catenulatum CP2829 (FERM BP-10533) and Bifidobacterium longum CP760 (FERM BP-10531). The inducer of T cell apoptosis of the invention is useful in the prevention and cure of a disease such as an organ-specific autoimmune disease or type I allergy. | ||||||
| 9 | MIXTURE OF LACTIC BACTERIA FOR THE PREPARATION OF GLUTEN FREE BAKED PRODUCTS | US14622587 | 2015-02-13 | US20150216185A1 | 2015-08-06 | Giammaria GIULIANI; Anna Benedusi; Raffaella Di Cagno; Maria De Angelis; Antonella Luisi; Marco Gobbetti |
| The present invention concerns a mixture of lactic bacteria for yeasting of gluten-free baked products. Particularly, the invention concerns the use of “natural yeast” based on selected lactic bacteria as yeasting agent for the production of gluten-free bread, with improved sensory and nutritional property, designed for celiac patients feeding. | ||||||
| 10 | LIPID METABOLISM AND/OR SUGAR METABOLISM IMPROVER CONTAINING LACTIC ACID BACTERIUM OR TREATMENT PRODUCT THEREOF | US14363150 | 2012-12-06 | US20140322172A1 | 2014-10-30 | Futoshi Nakamura; Nobuhisa Ashida; Yu Ishida; Shigeru Fujiwara |
| This invention provides the use of a microorganism capable of improving both lipid metabolism and sugar metabolism. Specifically, the invention relates to: a lipid metabolism and/or sugar metabolism improver comprising, as an active ingredient, a bacterial cell selected from bacteria belonging to the genus Lactobacillus and the genus Bifidobacterium, a treated product of the bacterial cell, or a mixture thereof, having dual-agonistic activities to peroxisome proliferator activated receptor (PPAR)α and peroxisome proliferator activated receptor (PPAR)γ; to a food or a beverage comprising the improver; and to a pharmaceutical composition comprising the improver. | ||||||
| 11 | LIPID METABOLISM AND/OR SUGAR METABOLISM IMPROVER CONTAINING LACTIC ACID BACTERIUM OR TREATMENT PRODUCT THEREOF | US15408722 | 2017-01-18 | US20170119828A1 | 2017-05-04 | Futoshi NAKAMURA; Nobuhisa ASHIDA; Yu ISHIDA; Shigeru FUJIWARA |
| This invention provides the use of a microorganism capable of improving both lipid metabolism and sugar metabolism. Specifically, the invention relates to: a lipid metabolism and/or sugar metabolism improver comprising, as an active ingredient, a bacterial cell selected from bacteria belonging to the genus Lactobacillus and the genus Bifidobacterium, a treated product of the bacterial cell, or a mixture thereof, having dual-agonistic activities to peroxisome proliferator activated receptor (PPAR)α and peroxisome proliferator activated receptor (PPAR)γ; to a food or a beverage comprising the improver; and to a pharmaceutical composition comprising the improver. | ||||||
| 12 | Mixture of lactic bacteria for the preparation of gluten free baked products | US12374246 | 2007-07-03 | US09237753B2 | 2016-01-19 | Giammaria Giuliani; Anna Benedusi; Raffaella Di Cagno; Maria De Angelis; Antonella Luisi; Marco Gobbetti |
| The present invention concerns a mixture of lactic bacteria for yeasting of gluten-free baked products. Particularly, the invention concerns the use of “natural yeast” based on selected lactic bacteria as yeasting agent for the production of gluten-free bread, with improved sensory and nutritional property, designed for celiac patients feeding. | ||||||
| 13 | MIXTURE OF LACTIC BACTERIA FOR THE PREPARATION OF GLUTEN FREE BAKED PRODUCTS | US12374246 | 2007-07-03 | US20100055238A1 | 2010-03-04 | Giammaria Giuliani; Anna Benedusi; Raffaella Di Cagno; Maria De Angelis; Antonella Luisi; Marco Gobbetti |
| The present invention concerns a mixture of lactic bacteria for yeasting of gluten-free baked products. Particularly, the invention concerns the use of “natural yeast” based on selected lactic bacteria as yeasting agent for the production of gluten-free bread, with improved sensory and nutritional property, designed for celiac patients feeding. | ||||||
| 14 | T Cell Apoptosis Inducer | US11883377 | 2006-03-06 | US20080166787A1 | 2008-07-10 | Shigeru Fujiwara; Hiroki Kanzato; Satoshi Hachimura |
| An inducer of T cell apoptosis and a health food for inducing T cell apoptosis comprising as an active ingredient of a lactic acid bacterium belonging to the genus Lactobacillus or the genus Bifidobacterium are disclosed. Particularly preferred lactic acid bacteria belonging to the genus Lactobacillus or the genus Bifidobacterium are Lactobacillus acidophilus L-92 (FERM BP-4981), Lactobacillus amylovorus CP1750 (FERM BP-10532), Bifidobacterium catenulatum CP2829 (FERM BP-10533) and Bifidobacterium longum CP760 (FERM BP-10531). The inducer of T cell apoptosis of the invention is useful in the prevention and cure of a disease such as an organ-specific autoimmune disease or type I allergy. | ||||||
| 15 | LIPID METABOLISM AND/OR SUGAR METABOLISM IMPROVER CONTAINING LACTIC ACID BACTERIUM OR TREATMENT PRODUCT THEREOF | EP12855562.0 | 2012-12-06 | EP2789340A1 | 2014-10-15 | The designation of the inventor has not yet been filed |
This invention provides the use of a microorganism capable of improving both lipid metabolism and sugar metabolism. Specifically, the invention relates to: a lipid metabolism and/or sugar metabolism improver comprising, as an active ingredient, a bacterial cell selected from bacteria belonging to the genus Lactobacillus and the genus Bifidobacterium, a treated product of the bacterial cell, or a mixture thereof, having dual-agonistic activities to peroxisome proliferator activated receptor (PPAR)α and peroxisome proliferator activated receptor (PPAR)γ; to a food or a beverage comprising the improver; and to a pharmaceutical composition comprising the improver. |
||||||
| 16 | T CELL APOPTOSIS INDUCER | EP06728662.5 | 2006-03-06 | EP1854468A1 | 2007-11-14 | FUJIWARA, S. Functional Food & Drink Dev. Lab.; KANZATO, Hiroki Functional Food & Drink Dev. Lab.; HACHIMURA, Satoshi Grad. School Agric.&Lifes Scie. |
An inducer of T cell apoptosis and a health food for inducing T cell apoptosis comprising as an active ingredient of a lactic acid bacterium belonging to the genus Lactobacillus or the genus Bifidobacterium are disclosed. Particularly preferred lactic acid bacteria belonging to the genus Lactobacillus or the genus Bifidobacterium are Lactobacillus acidophilus L-92 (FERM BP-4981), Lactobacillus amylovorus CP1750 (FERM BP-10532), Bifidobacterium catenulatum CP2829 (FERM BP-10533) and Bifidobacterium longum CP760 (FERM BP-10531). The inducer of T cell apoptosis of the invention is useful in the prevention and cure of a disease such as an organ-specific autoimmune disease or type I allergy. |
||||||
| 17 | T CELL APOPTOSIS INDUCER | EP06728662 | 2006-03-06 | EP1854468A4 | 2012-02-08 | FUJIWARA SHIGERU; KANZATO HIROKI; HACHIMURA SATOSHI |
| 18 | MIXTURE OF LACTIC ACID BACTERIA FOR THE PREPARATION OF GLUTEN FREE BAKED PRODUCTS | EP07805691.8 | 2007-07-03 | EP2046944A2 | 2009-04-15 | GIULIANI, Giammaria; BENEDUSI, Anna; DI CAGNO, Raffaella; DE ANGELIS, Maria; LUISI, Antonella; GOBBETTI, Marco |
| The present invention concerns a mixture of lactic bacteria for yeasting of gluten-free baked products. Particularly, the invention concerns the use of 'natural yeast'based on selected lactic bacteria as yeasting agent for the production of gluten-free bread, with improved sensory and nutritional property, designed for celiac patients feeding. | ||||||
| 19 | 乳酸菌又はその処理物を含む脂質代謝及び/又は糖代謝改善剤 | JP2015017278 | 2015-01-30 | JP6165185B2 | 2017-07-19 | 仲村 太志; 芦田 延久; 石田 優; 藤原 茂 |
| 20 | 乳酸菌又はその処理物を含む脂質代謝及び/又は糖代謝改善剤 | JP2015017278 | 2015-01-30 | JP2015108010A | 2015-06-11 | 仲村 太志; 芦田 延久; 石田 優; 藤原 茂 |
| 【課題】脂質代謝及び糖代謝の両方を改善する微生物のの提供。 【解決手段】ペルオキシソーム増殖剤応答性受容体(PPAR)α及びペルオキシソーム増殖剤応答性受容体(PPAR)γに対するデュアルアゴニスト活性をもつ、ラクトバチルス属及びビフィドバクテリウム属から選択される菌体、その菌体処理物又はそれらの混合物を有効成分として含む、脂質代謝及び/又は糖代謝改善剤、並びに、該改善剤を含む飲食品及び医薬組成物。 【選択図】図2 |
||||||
QQ群二维码
意见反馈
意见反馈